1. Highly homologous hS100A15 and hS100A7 proteins are distinctly expressed in normal breast tissue and breast cancer
- Author
-
Jason Winston, Peter H. Watson, Stuart H. Yuspa, Barbara K. Vonderhaar, Michele Gunsior, Paul K. Goldsmith, Alif Dharamsi, Christopher Voscopoulos, Ronald Wolf, and Melanie Olson
- Subjects
S100A7 ,Cancer Research ,Pathology ,medicine.medical_specialty ,CA 15-3 ,Estrogen receptor ,Breast Neoplasms ,Biology ,Article ,S100 Calcium Binding Protein A7 ,Breast cancer ,medicine ,Humans ,Breast ,skin and connective tissue diseases ,Calcium-Binding Proteins ,Carcinoma, Ductal, Breast ,S100 Proteins ,Myoepithelial cell ,Cancer ,medicine.disease ,Immunohistochemistry ,Receptors, Estrogen ,Oncology ,Female ,Receptors, Progesterone ,S100A15 - Abstract
Human S100A7 (psoriasin) is considered a marker for specific stages of breast cancer. hS100A15 is almost identical to hS100A7 and difficult to discriminate. We developed specific probes to distinguish hS100A7 and hS100A15, and demonstrate their differential distribution in normal breast tissue. Further, hS100A7 and S100A15 transcripts are elevated in ER/PR negative breast cancers, but hS100A15 protein is detected in all cancer specimens while hS100A7 protein is sporadically expressed. The differential regulation, expression and distribution of hS100A7 and hS100A15 and their reported distinct functions are compelling reasons to discriminate among these proteins in normal breast and breast cancers.
- Published
- 2009
- Full Text
- View/download PDF